YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

SEHK:1558 주식 보고서

시가총액: HK$8.0b

YiChang HEC ChangJiang Pharmaceutical 과거 수익 실적

과거 기준 확인 3/6

YiChang HEC ChangJiang Pharmaceutical의 수입은 연평균 -2.1%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 수입이 연평균 5.7%의 비율로 증가했습니다. 매출은 연평균 6%의 비율로 증가해 왔습니다. YiChang HEC ChangJiang Pharmaceutical의 자기자본이익률은 17.5%이고 순이익률은 29.7%입니다.

주요 정보

-2.1%

수익 성장률

-1.7%

EPS 성장률

Pharmaceuticals 산업 성장5.6%
매출 성장률6.0%
자기자본 수익률17.5%
순이익29.7%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Oct 07
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Recent updates

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Oct 07
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues

Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?

Sep 19
Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%

May 29
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%

Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?

Apr 23
Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce

Mar 01
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce

Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%

Mar 01
Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't

Jan 03
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt

Sep 25
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt

Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?

Nov 25
Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?

Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?

Mar 23
Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?

Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?

Oct 29
Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?

Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden

Apr 13
Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially

Mar 23
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially

YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.

Mar 13
YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?

Feb 20
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?

Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?

Feb 02
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Dec 26
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend

Dec 13
Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend

What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Nov 30
What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?

수익 및 비용 분석

YiChang HEC ChangJiang Pharmaceutical 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SEHK:1558 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 245,5401,6481,891360
31 Mar 245,9171,8201,915276
31 Dec 236,2951,9931,939192
30 Sep 235,9781,5661,870190
30 Jun 235,6611,1391,801187
31 Mar 234,7036081,676158
31 Dec 223,745771,551130
30 Sep 222,875-181,324115
30 Jun 222,005-1131,097101
31 Mar 221,459-351990105
31 Dec 21914-588883110
30 Sep 21690-43698698
30 Jun 21467-2851,08987
31 Mar 211,4072771,27890
31 Dec 202,3488391,46892
30 Sep 203,7921,2041,93374
30 Jun 205,2361,5682,39955
31 Mar 205,7301,7432,63427
31 Dec 196,2241,9192,8690
30 Sep 195,1621,5982,3560
30 Jun 194,0991,2761,8430
31 Mar 193,3051,1091,4410
31 Dec 182,5109431,0380
30 Sep 182,4669619680
30 Jun 182,4229808970
31 Mar 182,0128137310
31 Dec 171,6026475650
30 Sep 171,3255574430
30 Jun 171,0484673220
31 Mar 179954243180
31 Dec 169423813140
30 Sep 169043542940
30 Jun 168663272740
31 Mar 167792972360
31 Dec 156932661970
30 Sep 156372361900
30 Jun 155812071830
31 Mar 155111711770
31 Dec 144411351700
31 Dec 13316581410

양질의 수익: 1558 의 비현금 수입 수준이 높습니다.

이익 마진 증가: 1558 의 현재 순이익 이익률 (29.7%) 작년보다 높습니다 (20.1%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 1558 의 수입은 지난 5년 동안 매년 2.1% 씩 감소했습니다.

성장 가속화: 지난 1년간 1558 의 수익 증가율( 44.7% )은 연간 평균( -2.1% 초과합니다. ).

수익 대 산업: 지난 1년간 1558 수익 증가율( 44.7% )은 Pharmaceuticals 업계 6.4% 초과했습니다.


자기자본 수익률

높은 ROE: 1558 의 자본 수익률( 17.5% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기